You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/7906
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaptista, Daniela-
dc.contributor.authorBussadori, Karina-
dc.contributor.authorNunes-de-Souza, Ricardo Luiz-
dc.contributor.authorCanto-de-Souza, Azair-
dc.date.accessioned2014-05-20T13:25:00Z-
dc.date.accessioned2016-10-25T16:45:39Z-
dc.date.available2014-05-20T13:25:00Z-
dc.date.available2016-10-25T16:45:39Z-
dc.date.issued2009-10-06-
dc.identifierhttp://dx.doi.org/10.1016/j.brainres.2009.07.055-
dc.identifier.citationBrain Research. Amsterdam: Elsevier B.V., v. 1294, p. 29-37, 2009.-
dc.identifier.issn0006-8993-
dc.identifier.urihttp://hdl.handle.net/11449/7906-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/7906-
dc.description.abstractIntra-amygdala infusion of midazolam, a benzodiazepine receptor agonist, produces anxiolytic-like effects in mice when first exposed to the elevated plus-maze (EPM) and blocks antinociception induced in mice confined in the open arm of the EPM. However, benzodiazepines fail to alter anxiety in maze-experienced rodents, a phenomenon defined as "one-trial tolerance" (OTT). The main purpose of the present study was to investigate whether intra-amygdala midazolam attenuates the open ann-induced antinociception (OAA) in maze-experienced mice. Nociception was assessed by the writhing test (intraperitoneal injection of 0.6% acetic acid). In Experiment 1, nociception was recorded in maze-experienced mice without prior drug treatment. Experiment 2 investigated the effects of systemic midazolam (0.5, 1.0 and 2.0 mg/kg, s.c.), injected before EPM trial 2, on OAA in maze-experienced mice. in Experiment 3, the effects on OAA of intra-amygdala midazolam (30 nmol/0.1 mu l), injected before trial 1 (maze-naive) or before trial 2 (maze-experienced), were observed. The effects on OAA of intra-amygdala midazolam injected before trial 1 and trial 2 were also investigated (Experiment 4). The results showed that OAA remained unchanged in maze-experienced mice and was insensitive to systemic midazolam. However, intra-amygdala midazolam attenuated OAA in maze-naive mice, but not in maze-experienced mice. Even when given before both trial 1 and trial 2, intra-amygdala midazolam failed to alter OAA in maze-experienced mice. Taken together, these results confirm that the GABA(A)/benzodiazepine receptor complex located within the amygdala plays a role in OAA in maze-naive mice. The lack of effects following systemic or intra-amygdala midazolam on OAA in maze-experienced mice suggests that the OTT is also observed in the modulation of nociception and that the GABA(A)/benzodiazepine receptor located within this limbic forebrain structure participates in this process. (C) 2009 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.format.extent29-37-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectFearen
dc.subjectAntinociceptionen
dc.subjectAmygdalaen
dc.subjectMidazolamen
dc.subjectElevated plus-mazeen
dc.subjectMiceen
dc.titleBlockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experienceen
dc.typeoutro-
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUniversidade Federal de São Carlos (UFSCar), CECH, Dept Psicol, Grp Psicobiol, BR-13565905 São Carlos, SP, Brazil-
dc.description.affiliationUniversidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil-
dc.description.affiliationSão Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil-
dc.description.affiliationUnespUniversidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil-
dc.description.affiliationUnespSão Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil-
dc.description.sponsorshipIdFAPESP: 06/06855-4-
dc.description.sponsorshipIdCNPq: 309407/2006-0-
dc.identifier.doi10.1016/j.brainres.2009.07.055-
dc.identifier.wosWOS:000270658500004-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofBrain Research-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.